Lupin Ltd has received tentative approval from the FDA for its generic version of a combination HIV treatment.

Lupin receives tentative USFDA approval for its generic HIV treatment, combining Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide. The drug, equivalent to Janssen's Symtuza, has ...

The fixed-dose combination of Abacavir 60 mg/Dolutegravir 5 mg/Lamivudine 30 mg tablets for oral suspension is a once-daily ...

Real-world analyses have confirmed the efficacy of the 2-drug regimen of dolutegravir and lamivudine in treating HIV, ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) for Darunavir, Cobicistat, ...

Lupin has obtained approval from the USFDA to market a generic form of an HIV medication. The approved drug, equivalent to Symtuza tablets, positions Lupin as the exclusive first-to-file. The tablets ...

This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

Importantly, the programme has provided access to pre-exposure prophylaxis — a medicine that can prevent HIV infection — to 2 ...

Lupin has received USFDA approval to market a generic HIV medication in the US market, under the PEPFAR program. The drug ...